Holen Sie sich die Stockscreener-App
2.6628
5.50%
-0.1572
Schlusskurs vom Vortag:
$2.82
Offen:
$2.81
24-Stunden-Volumen:
609.19K
Relative Volume:
0.54
Marktkapitalisierung:
$151.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-82.44M
KGV:
-1.4164
EPS:
-1.88
Netto-Cashflow:
$-66.75M
1W Leistung:
-14.58%
1M Leistung:
+7.46%
6M Leistung:
+1.72%
1J Leistung:
-56.24%
1-Tages-Spanne:
$2.66
$2.8536
1-Wochen-Bereich:
$2.66
$3.15
52-Wochen-Spanne:
$1.195
$6.75
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Firmenname
Black Diamond Therapeutics Inc
Sektor
Branche
Telefon
617-417-5868
Adresse
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Vergleichen Sie BDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.66 | 158.08M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.56 | 120.29B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.87 | 60.26B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
388.94 | 43.10B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.23 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 33.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Fortgesetzt | Raymond James | Outperform |
| 2024-07-31 | Eingeleitet | Raymond James | Outperform |
| 2023-07-14 | Eingeleitet | Piper Sandler | Overweight |
| 2023-06-30 | Hochstufung | Stifel | Hold → Buy |
| 2023-06-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-03-29 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-03-22 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | Eingeleitet | Stifel | Hold |
| 2021-01-07 | Eingeleitet | Wedbush | Outperform |
| 2020-11-24 | Eingeleitet | Berenberg | Buy |
| 2020-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-02-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-02-24 | Eingeleitet | Cowen | Outperform |
| 2020-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2020-02-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Black Diamond Therapeutics Inc Aktie (BDTX) Neueste Nachrichten
Historical volatility pattern of Black Diamond Therapeutics Inc. visualizedFree Low Risk High Return Opportunities - Newser
Chart based analysis of Black Diamond Therapeutics Inc. trendsFree Top Gaining Picks With Entry Signals - Newser
How to use a screener to detect Black Diamond Therapeutics Inc. breakoutsFree Entry Plan for Oversold Reversal Stocks - Newser
Sentiment analysis tools applied to Black Diamond Therapeutics Inc.Momentum Detection with Entry Optimization - Newser
Will Black Diamond Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Value Investing Picks With Stability - Newser
Published on: 2025-07-29 16:50:08 - metal.it
Technical Charts Suggest Momentum Shift in Black Diamond Therapeutics Inc. - metal.it
Using data tools to time your Black Diamond Therapeutics Inc. exitBuy Signal Forecast With Short-Term Data - Newser
Why Black Diamond Therapeutics Inc. stock attracts strong analyst attentionStock Holding Strategy Long-Term Summary Sheet - Newser
How Black Diamond Therapeutics Inc. stock performs during market volatilitySmart Money Strategy for Growth Stocks - Newser
Quant Funds Rotate Into Black Diamond Therapeutics Inc. StockHigh Win Rate Trading Opportunities Detected - metal.it
What is the dividend policy of Black Diamond Therapeutics Inc. stockUnlock expert trading strategies for growth - jammulinksnews.com
Does Black Diamond Therapeutics Inc. stock perform well during market downturnsMarket-crushing profits - jammulinksnews.com
Using portfolio simulators with Black Diamond Therapeutics Inc. includedFree Capital Preserving Trade Plan Templates - Newser
Is Black Diamond Therapeutics Inc. a Top Dividend Stock to Watch in 2025Free Profit Target Stock Opportunity Monitor - Newser
What institutional investors are buying Black Diamond Therapeutics Inc. stockChart Pattern Guidance To Watch Now - jammulinksnews.com
What are analysts’ price targets for Black Diamond Therapeutics Inc. in the next 12 monthsInvest smarter with expert trading signals - jammulinksnews.com
What are the latest earnings results for Black Diamond Therapeutics Inc.Capitalize on momentum-driven investment opportunities - jammulinksnews.com
What are Black Diamond Therapeutics Inc. company’s key revenue driversMaximize returns with disciplined trading approaches - jammulinksnews.com
Is Black Diamond Therapeutics Inc. Stock a Good Fit for Conservative InvestorsHigh Accuracy Alerts - metal.it
Is Black Diamond Therapeutics Inc. a growth stock or a value stockMaximize returns with timely market signals - jammulinksnews.com
Competitive Positioning of Black Diamond Therapeutics Inc.: Is It Leading or LaggingMinimized Risk Maximum Return - Newser
Is Black Diamond Therapeutics Inc. a good long term investmentUnrivaled growth potential - PrintWeekIndia
Black Diamond Therapeutics Inc. Stock Analysis and ForecastSignificant capital appreciation - PrintWeekIndia
What analysts say about Black Diamond Therapeutics Inc. stockFastest-growing stock picks - PrintWeekIndia
What drives Black Diamond Therapeutics Inc. stock priceTriple-digit growth rates - jammulinksnews.com
Finanzdaten der Black Diamond Therapeutics Inc-Aktie (BDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Black Diamond Therapeutics Inc-Aktie (BDTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Aug 28 '24 |
Sale |
6.32 |
221,600 |
1,400,556 |
3,726,341 |
3.80%
1.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):